New research explores the GSK-3β/mTOR axis as a potential target to overcome chemoresistance in gestational choriocarcinoma. This study highlights molecular mechanisms and therapeutic opportunities that could enhance treatment efficacy.
targeting the gsk 3 mtor axis to overcome chemoresistance in gestational choriocarcinoma molecular mechanisms and therapeutic opportunities
Original title: “Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.”